Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-Alanyl-D-alanine terminus of bacterial cell wall precursors is a dipeptide motif located at the end of the peptidoglycan pentapeptide in the cell wall precursors of most Gram-positive and some Gram-negative bacteria. This motif is essential for cross-linking peptidoglycan strands, a process critical for maintaining bacterial cell wall strength and integrity. Many antibiotics, notably glycopeptides such as vancomycin, exert their activity by binding tightly to the D-Ala-D-Ala terminus, thereby sterically blocking enzymes required for peptidoglycan cross-linking and inhibiting cell wall biosynthesis, which leads to bactericidal activity. Resistance to these drugs often arises through modification of the target terminus, most commonly via substitution of D-Ala-D-Lac in pathogenic bacteria, drastically reducing drug binding and efficacy. The D-Ala-D-Ala motif is not present in mammalian cells, making it a selective and valuable point of therapeutic intervention for bacterial infections.
Drugs like vancomycin bind the D-Ala-D-Ala terminus, sterically blocking peptidoglycan cross-linking enzymes (transglycosylase and transpeptidase) and inhibiting cell wall synthesis, leading to bacterial cell death. β-lactam antibiotics mimic the D-Ala-D-Ala structure and irreversibly acylate the active site serine of transpeptidases, blocking cell wall cross-linking. D-cycloserine inhibits D-alanine racemase and D-Ala-D-Ala ligase, blocking D-Ala-D-Ala synthesis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-Alanyl-D-alanine terminus of bacterial cell wall precursor (D-Ala-D-Ala terminus).